Pan Wang
State Key Laboratory Of Female Fertility Promotion
Beijing, 100191, China
Beijing, 100191, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Migrasome-mediated clearance of excess PLK4 defines a targetable vulnerability.
Journal: EBioMedicine
Published: October 23, 2025
Malignant ascites enhance γδ T cell cytotoxicity toward ovarian cancer via chemokine-mediated recruitment.
Journal: Cancer biology & medicine
Published: June 06, 2025
Small extracellular vesicle-based one-step high-throughput microfluidic platform for epithelial ovarian cancer diagnosis.
Journal: Journal of nanobiotechnology
Published: December 16, 2024
Multiple Biomarker Simultaneous Detection in Serum via a Nanomaterial-Functionalized Biosensor for Ovarian Tumor/Cancer Diagnosis.
Journal: Micromachines
Published: November 01, 2022
Profiling the metabolome of uterine fluid for early detection of ovarian cancer.
Journal: Cell reports. Medicine
Published: September 15, 2022
The Apoptotic Resistance of BRCA1-Deficient Ovarian Cancer Cells is Mediated by cAMP.
Journal: Frontiers in cell and developmental biology
Published: March 04, 2022
A synergetic effect of BARD1 mutations on tumorigenesis.
Journal: Nature communications
Published: March 03, 2020
Alisol A is potentially therapeutic in human breast cancer cells.
Journal: Oncology reports
Published: December 23, 2019
BRCA2 deficiency is a potential driver for human primary ovarian insufficiency.
Journal: Cell death & disease
Published: May 08, 2019
Showing 1-9 of 9
Last Updated: 09/26/2026